Isis Pharmaceuticals, Inc. (ISIS) Announces Its R&D Webcast Presentation
11/19/2009 11:04:35 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Cholesterol Drug Meets All Goals of Key Trial
11/17/2009 8:31:13 AM
More...
|
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Announce Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at American Heart Association
11/17/2009 8:23:14 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results and Highlights for Third Quarter of 2009 Conference Call Webcast
11/5/2009 9:32:01 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 2009 Canaccord Adams Cardiovascular Conference
11/3/2009 10:33:51 AM
More...
|
Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials
10/29/2009 7:29:52 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Diabetes Drug Shows Promise in Mid-Stage
10/22/2009 7:01:32 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 4th Annual BIOCOM Investor Conference
10/20/2009 10:47:15 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 4th Annual JMP Securities Healthcare Focus Conference
9/29/2009 9:35:50 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
9/10/2009 8:16:51 AM
More...
|
|